Alpha 2.0
Login Register
» Articles » PMID: 28520553

CDC's Public Health Surveillance of Cancer

Overview
Journal Prev Chronic Dis
Specialty Public Health
Date 2017 May 19
PMID 28520553
Citations 18
Authors
A Blythe Ryerson
Greta M Massetti
Affiliations
Soon will be listed here.
Abstract

Routine data collection efforts are a necessary, often underappreciated, component of nearly all cancer research and prevention efforts. Public health cancer surveillance data are crucial for identifying needs, planning interventions, directing public health resources, and evaluating the overall effectiveness of initiatives aimed at preventing or treating cancer and its negative health consequences. As the nation's health protection agency, the Centers for Disease Control and Prevention (CDC) provides resources for disease surveillance systems to help protect our nation against expensive and dangerous health threats, including cancer. Therefore, public health surveillance is a core function of CDC. In this article we briefly describe CDC's approach to cancer surveillance in our public health programs and other federal initiatives to monitor cancer-related outcomes. We also describe our premier cancer incidence surveillance system, the National Program of Cancer Registries, and discuss uses and applications of the program's critical cancer data.

Citing Articles

An Investigation of Travel Distance and Timeliness of Breast Cancer Treatment Among a Diverse Cohort in the United States.

Adams S, Babatunde O, Zahnd W, Hung P, Wickersham K, Bell N Int J Environ Res Public Health. 2025; 22(2).

PMID: 40003402 PMC: 11855575. DOI: 10.3390/ijerph22020176.

Consensus-based framework for evaluating data modernization initiatives: the case of cancer registration and electronic reporting.

Subramanian S, Tangka F, Pordell P, Beizer J, Wilson R, Jones S JAMIA Open. 2023; 6(3):ooad060.

PMID: 37638125 PMC: 10448993. DOI: 10.1093/jamiaopen/ooad060.

Is There Really a Difference in Outcomes between Men and Women with Hepatocellular Cancer?.

Fa A, Danos D, Maniscalco L, Yi Y, Wu X, Maluccio M Cancers (Basel). 2023; 15(11).

PMID: 37296854 PMC: 10251901. DOI: 10.3390/cancers15112892.

Integration of Cancer Screening Data into Routine Cancer Surveillance Systems: A Florida Pilot Project.

Hernandez M, Levin G, Hylton T, Pordell P, White A, Senkomago V J Registry Manag. 2023; 49(4):132-138.

PMID: 37260814 PMC: 10229182.

Clinical outcomes in patients with solid tumors living in rural and urban areas followed via telemedicine: experience in a highly complex latin american hospital.

Restrepo J, Alarcon J, Hernandez A, Sangiovanni S, Gonzalez S, Gallego K BMC Cancer. 2023; 23(1):253.

PMID: 36927771 PMC: 10018944. DOI: 10.1186/s12885-023-10717-5.

References
1.
Saraiya M, Unger E, Thompson T, Lynch C, Hernandez B, Lyu C . US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015; 107(6):djv086. PMC: 4838063. DOI: 10.1093/jnci/djv086. View
2.
Ryerson A, Eheman C, Altekruse S, Ward J, Jemal A, Sherman R . Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer. 2016; 122(9):1312-37. PMC: 4840031. DOI: 10.1002/cncr.29936. View
3.
Chen V, Eheman C, Johnson C, Hernandez M, Rousseau D, Styles T . Enhancing cancer registry data for comparative effectiveness research (CER) project: overview and methodology. J Registry Manag. 2014; 41(3):103-12. PMC: 4524450. View
4.
Wu M, Austin H, Eheman C, Myles Z, Miller J, Royalty J . A comparative analysis of breast cancer stage between women enrolled in the National Breast and Cervical Cancer Early Detection Program and women not participating in the program. Cancer Causes Control. 2015; 26(5):751-8. PMC: 4612348. DOI: 10.1007/s10552-015-0548-x. View
5.
Rodriguez J, Hawkins N, Berkowitz Z, Li C . Factors Associated with Health-Related Quality of Life Among Colorectal Cancer Survivors. Am J Prev Med. 2015; 49(6 Suppl 5):S518-27. PMC: 6334761. DOI: 10.1016/j.amepre.2015.08.007. View